Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308033PMC
http://dx.doi.org/10.1016/j.jaccao.2023.04.002DOI Listing

Publication Analysis

Top Keywords

atorvastatin attenuate
4
attenuate aortic
4
aortic stiffening
4
stiffening doxorubicin
4
doxorubicin breast
4
breast cancer
4
cancer lymphoma
4
lymphoma prevent-wf-98213
4
atorvastatin
1
aortic
1

Similar Publications

Aims: Recurrent acute myocardial infarction (RE-AMI) is a frequent complication after STEMI, and its association with stent thrombosis can be life-threatening. Intravenous atorvastatin (IV-atorva) administration during AMI has been shown to limit infarct size and adverse cardiac remodeling. We determined by cardiac magnetic resonance (CMR) whether the cardioprotection exerted by IV-atorva at the index AMI event translates into a better prognosis upon RE-AMI in dyslipidemic pigs.

View Article and Find Full Text PDF

This study is aimed at investigating the effects of atorvastatin (ATV) on endothelial cell injury in atherosclerosis (AS) through inhibiting acyl-CoA synthetase long-chain family member 4 (ACSL4)-mediated ferroptosis. Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low-density lipoprotein (ox-LDL) to establish an in vitro model of AS. The cell viability, lactate dehydrogenase (LDH) release, apoptosis, and expression levels of apoptotic proteins were assessed.

View Article and Find Full Text PDF

Short-term effect of atorvastatin on renal oxidative stress, inflammation, and fibrosis in a rat model of streptozotocin-induced diabetes.

J Diabetes Metab Disord

June 2025

Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, P.O. Box 566, Irbid, 21163 Jordan.

Objectives: Diabetes mellitus (DM) contributes to the development and progression of nephropathy and kidney diseases. Statins are known to have anti-inflammatory and antifibrotic effects. We aimed to test the short-term effect of atorvastatin on renal biomarkers of oxidative damage, inflammation, and fibrosis in a rat model of streptozotocin-induced DM.

View Article and Find Full Text PDF

Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease.

J Intern Med

January 2025

Division of Cardiovascular Medicine, Center for Molecular Medicine, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

Background And Objectives: Statins are used for metabolic dysfunction-associated steatotic liver disease (MASLD) (NAFLD) treatment, but their role in this context is unclear. Genetic variants of patatin-like phospholipase domain containing 3 (PNPLA3) are associated with MASLD susceptibility and statin treatment efficacy. Access to liver biopsies before established MASLD is limited, and statins and PNPLA3 in early liver steatosis are thus difficult to study.

View Article and Find Full Text PDF

Atorvastatin facilitates extinction and prevents reinstatement of morphine-induced conditioned place preference in rats.

Biomed Pharmacother

December 2024

School of Cognitive Sciences, Institute for Research in Fundamental Sciences, IPM, Tehran, Iran; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address:

Article Synopsis
  • Opioid addiction is a chronic disorder that leads to compulsive behavior and high relapse rates, despite current treatments targeting mu-opioid receptors.
  • This study investigated the effect of atorvastatin, a statin that crosses the blood-brain barrier, on preventing relapse in male rats using different models of drug-seeking behavior.
  • Results showed that atorvastatin significantly reduced morphine-seeking behavior, potentially by increasing brain-derived neurotrophic factor (BDNF) in key brain areas and altering neuronal activity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!